PPARA and myeloid sarcoma: For instance, in EAE (experimental autoimmune encephalomyelitis, an animal model of MS), several PPAR agonists have proven effective in delaying the onset and progression of disease (Niino et al., 2001; Diab et al., 2002, 2004; Feinstein et al., 2002; Gocke et al., 2009).